Sandra Meyer

Affiliated with

Research Area

Biography

Sandra Meyer has not added Biography.
If you are Sandra Meyer and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 1	Year
Publication title Cited by 38	2015

Other Publications

Article	Year
The German network of excellence for viral hepatitis (Hep-Net). Hepatology (Baltimore, Md.)\| PubMed ID: 12939578	2003
Short-time infusion of fish oil-based lipid emulsions, approved for parenteral nutrition, reduces monocyte proinflammatory cytokine generation and adhesive interaction with endothelium in hu... Journal of immunology (Baltimore, Md. : 1950)\| PubMed ID: 14568963	2003
Discovery and selection of TMC114, a next generation HIV-1 protease inhibitor. Journal of medicinal chemistry\| PubMed ID: 15771427	2005
Design of HIV-1 protease inhibitors active on multidrug-resistant virus. Journal of medicinal chemistry\| PubMed ID: 15771440	2005
TMC114/ritonavir substitution for protease inhibitor(s) in a non-suppressive antiretroviral regimen: a 14-day proof-of-principle trial. AIDS (London, England)\| PubMed ID: 15905675	2005
TMC114, a novel human immunodeficiency virus type 1 protease inhibitor active against protease inhibitor-resistant viruses, including a broad range of clinical isolates. Antimicrobial agents and chemotherapy\| PubMed ID: 15917527	2005
DC-SIGN mediates binding of dendritic cells to authentic pseudo-LewisY glycolipids of Schistosoma mansoni cercariae, the first parasite-specific ligand of DC-SIGN. The Journal of biological chemistry\| PubMed ID: 16155001	2005
Discovery of complex mixtures of novel long-chain quorum sensing signals in free-living and host-associated marine alphaproteobacteria. Chembiochem : a European journal of chemical biology\| PubMed ID: 16283687	2005
One-step biotinylation procedure for carbohydrates to study carbohydrate-protein interactions. Analytical biochemistry\| PubMed ID: 16713984	2006
Safety and efficacy of darunavir (TMC114) with low-dose ritonavir in treatment-experienced patients: 24-week results of POWER 3. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 17621237	2007
The C-type lectin L-SIGN differentially recognizes glycan antigens on egg glycosphingolipids and soluble egg glycoproteins from Schistosoma mansoni. Glycobiology\| PubMed ID: 17621595	2007
Response to "key amprenavir resistance mutations counteract dramatic efficacy of darunavir in highly experienced patients". AIDS (London, England)\| PubMed ID: 18090413	2008
Resistance profile of darunavir: combined 24-week results from the POWER trials. AIDS research and human retroviruses\| PubMed ID: 18327986	2008
Efficacy and safety of once-daily darunavir/ritonavir versus lopinavir/ritonavir in treatment-naive HIV-1-infected patients at week 48. AIDS (London, England)\| PubMed ID: 18614861	2008
Efficacy of once-daily darunavir/ritonavir 800/100 mg in HIV-infected, treatment-experienced patients with no baseline resistance-associated mutations to darunavir. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 18769351	2008
Influence of baseline protease inhibitor resistance on the efficacy of darunavir/ritonavir or lopinavir/ritonavir in the TITAN trial. Journal of acquired immune deficiency syndromes (1999)\| PubMed ID: 19202459	2008
Transglycosylation-based fluorescent labeling of 6-gala series glycolipids by endogalactosylceramidase. Glycobiology\| PubMed ID: 19389917	2009
Characterization of virologic failure patients on darunavir/ritonavir in treatment-experienced patients. AIDS (London, England)\| PubMed ID: 19474650	2009
Multipotent adult germline stem cells and embryonic stem cells: comparative proteomic approach. Journal of proteome research\| PubMed ID: 19810753	2009
Efficacy and safety of darunavir/ritonavir in treatment-experienced HIV type-1 patients in the POWER 1, 2 and 3 trials at week 96. Antiviral therapy\| PubMed ID: 19812449	2009
Inulin solid dispersion technology to improve the absorption of the BCS Class IV drug TMC240. European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik e.V\| PubMed ID: 19861163	2010
Co-localisation of hypoxia and perfusion markers with parameters of glucose metabolism in human squamous cell carcinoma (hSCC) xenografts. International journal of radiation biology\| PubMed ID: 19895274	2009
Glycolytic metabolism and tumour response to fractionated irradiation. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology\| PubMed ID: 20036432	2010
[Diagnosis of delirium]. Therapeutische Umschau. Revue thérapeutique\| PubMed ID: 20131214	2010
[Drug-induced delirium]. Therapeutische Umschau. Revue thérapeutique\| PubMed ID: 20131216	2010
Etravirine limits the emergence of darunavir and other protease inhibitor resistance-associated mutations in the DUET trials. AIDS (London, England)\| PubMed ID: 20160633	2010
Schistosoma mansoni worm glycolipids induce an inflammatory phenotype in human dendritic cells by cooperation of TLR4 and DC-SIGN. Molecular immunology\| PubMed ID: 20170964	2010
Short communication: activity of etravirine on different HIV type 1 subtypes: in vitro susceptibility in treatment-naive patients and week 48 pooled DUET study data. AIDS research and human retroviruses\| PubMed ID: 20507207	2010
Digital gene expression signatures for maize development. Plant physiology\| PubMed ID: 20833728	2010
In vitro susceptibility and virological outcome to darunavir and lopinavir are independent of HIV type-1 subtype in treatment-naive patients. Antiviral therapy\| PubMed ID: 21149923	2010
Virological characterization of patients failing darunavir/ritonavir or lopinavir/ritonavir treatment in the ARTEMIS study: 96-week analysis. Antiviral therapy\| PubMed ID: 21311113	2011
Multipotent adult germline stem cells and embryonic stem cells functional proteomics revealed an important role of eukaryotic initiation factor 5A (Eif5a) in stem cell differentiation. Journal of proteome research\| PubMed ID: 21344951	2011
Telaprevir for retreatment of HCV infection. The New England journal of medicine\| PubMed ID: 21696308	2011
Week 96 efficacy, virology and safety of darunavir/r versus lopinavir/r in treatment-experienced patients in TITAN. Current HIV research\| PubMed ID: 22339125	2012
Hepatitis C viral evolution in genotype 1 treatment-naïve and treatment-experienced patients receiving telaprevir-based therapy in clinical trials. PloS one\| PubMed ID: 22511937	2012
Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: results from the REALIZE trial. Hepatology (Baltimore, Md.)\| PubMed ID: 22806681	2012
Hepatitis C virus variants with decreased sensitivity to direct-acting antivirals (DAAs) were rarely observed in DAA-naive patients prior to treatment. Journal of virology\| PubMed ID: 23152524	2013
Sustained virologic response rates with telaprevir by response after 4 weeks of lead-in therapy in patients with prior treatment failure. Journal of hepatology\| PubMed ID: 23183521	2013
Limited impact of IL28B genotype on response rates in telaprevir-treated patients with prior treatment failure. Journal of hepatology\| PubMed ID: 23321318	2013
Virological analysis of once-daily and twice-daily darunavir/ritonavir in the ODIN trial of treatment-experienced patients. Antiviral therapy\| PubMed ID: 23558157	2013
Evolution of treatment-emergent resistant variants in telaprevir phase 3 clinical trials. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America\| PubMed ID: 23575197	2013
Duplicated STM-like KNOX I genes act in floral meristem activity in Eschscholzia californica (Papaveraceae). Development genes and evolution\| PubMed ID: 23636178	2013
Telaprevir activity in treatment-naive patients infected hepatitis C virus genotype 4: a randomized trial. The Journal of infectious diseases\| PubMed ID: 23801602	2013
Telaprevir twice daily is noninferior to telaprevir every 8 hours for patients with chronic hepatitis C. Gastroenterology\| PubMed ID: 24316262	2014
Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology\| PubMed ID: 24462470	2014
Synthesis and pharmacological evaluation of a new series of radiolabeled ligands for 5-HT7 receptor PET neuroimaging. Nuclear medicine and biology\| PubMed ID: 24607435	2014
Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir. Virology journal\| PubMed ID: 24886541	2014
Deep-sequencing analysis of the gene encoding the hepatitis C virus nonstructural 3-4A protease confirms a low prevalence of telaprevir-resistant variants at baseline and the end of the REAL... The Journal of infectious diseases\| PubMed ID: 24943725	2014
Modeling viral evolutionary dynamics after telaprevir-based treatment. PLoS computational biology\| PubMed ID: 25101970	2014
Low-density lipoprotein and other predictors of response with telaprevir-based therapy in treatment-experienced HCV genotype 1 patients: REALIZE study. Liver international : official journal of the International Association for the Study of the Liver\| PubMed ID: 25319731	2015
Virology analyses of HCV isolates from genotype 1-infected patients treated with simeprevir plus peginterferon/ribavirin in Phase IIb/III studies. Journal of hepatology\| PubMed ID: 25445400	2015
Effect of Agrobacterium strain and plasmid copy number on transformation frequency, event quality and usable event quality in an elite maize cultivar. Plant cell reports\| PubMed ID: 25558819	2015
Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region. Antiviral research\| PubMed ID: 25614456	2015
DPP4-deficient congenic rats display blunted stress, improved fear extinction and increased central NPY. Psychoneuroendocrinology\| PubMed ID: 25635612	2015
An OPTIMIZE study retrospective analysis for management of telaprevir-treated hepatitis C virus (HCV)-infected patients by use of the Abbott RealTime HCV RNA assay. Journal of clinical microbiology\| PubMed ID: 25653396	2015
Trends in darunavir resistance-associated mutations and phenotypic resistance in commercially tested United States clinical samples between 2006 and 2012. AIDS research and human retroviruses\| PubMed ID: 25684627	2015
Evolution of hepatitis C virus quasispecies during repeated treatment with the NS3/4A protease inhibitor telaprevir. Antimicrobial agents and chemotherapy\| PubMed ID: 25712364	2015